traconpharma.com (TCON) - Company Sales Revenue

traconpharma.com - graphic logo of issuer TCON

Management allowed the complete collapse of the business and the liquidation of assets following failed tests. TRACON Pharmaceuticals (TCON) sales revenue clearly demonstrates this decline, where the current status equals 0.01. Previously, TRACON Pharmaceuticals (TCON) optimized costs through partnerships with CRO centers, while the implementation of its own research unit reduced drug development timelines, which was intended to accelerate the time-to-market for its products.

TRACON Pharmaceuticals, Inc (TCON): Company Revenue from 07/04/2022 to 08/04/2024

Comprehensive metric breakdowns and analytics for TRACON Pharmaceuticals Inc. (TCON)

Summary company analysis:TCON TRACON Pharmaceuticals
Signature product of TRACON Pharmaceuticals, Inc.

This indicator captures the aggregate cash flow from product sales, serving as a measure of business strategy execution efficiency and capital resilience against drawdowns. By analyzing the gross sales volume of TRACON Pharmaceuticals (TCON), an investor can see a critical collapse in revenue, which confirms a total loss of market position and the cessation of operations following failed clinical trials.

Key competitors

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Revenue and Sales Volume SLN (Silence Therapeutics PLC)|Company Sales Revenue PRQR|CDXS - Company Revenue|SGMO (Sangamo Therapeutics) - Company Sales Volume|NAUT: Revenue and Sales Volume|Company Sales Volume MGX|DTIL (precisionbiosciences.com) - Revenue and Sales Volume|Company Sales Volume GBIO (Generation Bio Co.)|Company Revenue Boundless Bio (BOLD)|Exicure - Company Sales Volume|Revenue and Sales Volume IMNN (imunon.com)|Company Gross Revenue Phio Pharmaceuticals (PHIO)|MBIO: Company Sales|Company Sales Revenue RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Company Revenue|APDN - Company Gross Revenue|Company Sales BLUE|Revenue and Sales Volume immunoprecise.com|Revenue and Sales Volume OMGA|Company Gross Revenue Singular Genomics Corp|Regulus Therapeutics - Company Sales|SYRS (Syros Pharmaceuticals) - Company Annual Revenue|Telesis Bio Inc. - Revenue and Sales Volume|Unity Biotechnology, Inc. (UBX) - Company Sales